Journals / Turkish Thoracic Journal / 2016 / Cilt: 17 - Sayı: 1

Effect of Nasal Continuous Positive Airway Pressure Therapy on the Functional Respiratory Parameters and Cardiopulmonary Exercise Test in Obstructive Sleep Apnea Syndrome

Pages
1–6
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no significant change in body composition analysis, spirometric parameters, and lung volumes.CONCLUSION: In a short time period, nCPAP can improve exercise capacity, respiratory muscle strength, and the health-related quality of life scores and help control blood pressure

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: Nasal continuous positive airway pressure (nCPAP) treatment is the gold standard treatment for obstructive sleep apnea syndrome (OSAS).
📊
Key Findings & Data:In this study, we aimed to show that the pulmonary functions, exercise limitation on the cardiopulmonary exercise test (CPET), and the health-related quality of life can be improved after a short treatment period by nCPAP.MATERIALS AND METHODS: Our case group with severe obstructive sleep apnea (OSA) performed incremental CPET before and after 8 weeks of nCPAP treatment.
💡
Conclusion & Impact:There was no significant change in body composition analysis, spirometric parameters, and lung volumes.CONCLUSION: In a short time period, nCPAP can improve exercise capacity, respiratory muscle strength, and the health-related quality of life scores and help control blood pressure
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: Nasal continuous positive airway pressure (nCPAP) treatment is the gold standard treatment for obstructive sleep apnea syndrome (OSAS). In this study, we aimed to show that the pulmonary functions, exercise limitation on the cardiopulmonary exercise test (CPET), and the health-related quality of life can be improved after a short treatment period by nCPAP.MATERIALS AND METHODS: Our case group with severe obstructive sleep apnea (OSA) performed incremental CPET before and after 8 weeks of nCPAP treatment. All the subjects also underwent physical examination, body composition analysis, simple spirometric measurements, maximal inspiratory pressure (PImax)-maximal expiratory pressure (PEmax), and lung volume tests before and after nCPAP treatment.RESULTS: Thirty-one patients (4 female, 27 male) completed the study. The mean age of the patients was 53.41 ± 1.46 years. Sixteen had at least one comorbidity. In addition, 17 of the subjects were ex-smokers. After nCPAP treatment for 8 weeks, higher PImax-PEmax (p< 0.05), peak oxygen uptake (p= 0.001), workpeak (p= 0.000), maximal heart rates (p= 0.000), and short form-36 scores (p< 0.05) were observed. nCPAP treatment helped control the blood pressure (p= 0.005). There was no significant change in body composition analysis, spirometric parameters, and lung volumes.CONCLUSION: In a short time period, nCPAP can improve exercise capacity, respiratory muscle strength, and the health-related quality of life scores and help control blood pressure

🔖

Cite This Article

TAPAN, Ö. O., SEVİNÇ, C., İTİL, B. O., ÖZTURA, İ., KAYATEKİN, B. M., DEMİRAL, Y. (2016). Effect of Nasal Continuous Positive Airway Pressure Therapy on the Functional Respiratory Parameters and Cardiopulmonary Exercise Test in Obstructive Sleep Apnea Syndrome. Turkish Thoracic Journal, Cilt: 17 - Sayı: 1, 1–6. https://ajindex.com/articles/418133

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. American Academy of Sleep Medicine, International Classification of Sleep Disorders, version 2: Diagnostic Coding Manual, 2005
  2. McNicholas WT, Bonsignore MR; Management Committee of EU COST ACTION B26. Sleep apnea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78. [CrossRef] 3. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005;142:187-97. [CrossRef] 4. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004;79:1036-46. [CrossRef] 5. Levinson PD, McGarvey ST, Carlisle CC, et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993;103:1336-42. [CrossRef] 6. Zerah-Lancner F, Lofaso F, Coste A, et al. Pulmonary function in obese snorers with or without sleep apnea syndrome. Am J Respir Crit Care Med 1997;156:522-7. [CrossRef] 7. Ozturk L, Metin G, Cuhadaroglu C, et al. FEF(25-75)/FVC Measurements and extrathoracic airway obstruction in obstructive sleep apnea patients. Sleep Breath 2005;9:33-8. [CrossRef] 8. Hoffstein V, Wright S, Zamel N. Flow volume curves in snoring patients with and without obstructive sleep apnea. Am Rev Respir Dis 1989;139:957-60. [CrossRef] 9. Rauscher H, Popp W, Zwick H. Flow-volume curves in obstructive sleep apnea and snoring. Lung 1990;168:209-14. [CrossRef] 10. Ray CS, Sue DY, Bray G, et al. Effect of obesity on respiratory function. Am Rev Respir Dis 1983;128:501-6. [CrossRef] 11. Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest 2006;130:827-33. [CrossRef] 12. Peppard PE, Young T. Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep 2004;27:480-4
  3. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. [CrossRef] 14. Jing J, Huang T, Cui W, Shen H. Effect on quality of life of continuous positive airway pressure in patients with obstructive sleep apnea syndrome: a meta-analysis. Lung 2008;186:131-44. [CrossRef] 15. Oztürk LM, Metin G, Cuhadaroglu C, et al. Cardiopulmonary responces to exercise in moderate-to-severe obstructive sleep apnea. Tuberk Toraks 2005;53:10-9
  4. Lin CC, Hsieh WY, Chou CS, Liaw SF. Cardiopulmonary exercise testing in obstructive sleep apnea syndrome. Respir